IOME BIO Alternatives & Competitors
12 companies similar to IOME BIO — Harnessing unique, proprietary microbiome insights to unlock the efficacy of imm...
Companies similar to IOME BIO
Farcast Biosciences
24,000 human tumors and counting - building the most precise functional precision tumor mi...
Bengaluru, India
Imugene Limited
Bringing Effective New Treatments And Options To Patients Who Need Them
Australia
GamaMabs Pharma
Advancing the future of immuno-oncology with innovative monoclonal antibody treatments
Rival Readout
Competing with IOME BIO? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
Foster City, United State...
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Duet BioTherapeutics
A Scopus BioPharma company creating targeted immunotherapies for treatment-resistant cance...
Los Angeles, United State...
Seekyo Therapeutics
Tumor Activated Therapy: targeting Tumor Micro-Environment functional proteins to induce...
Poitiers, France
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Vidac Pharma
New Paradigm in Cancer Drug Discovery: Dissociating HK2/VDAC and pro-immune Tumor microenv...
Ness Ziona, Israel
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
About IOME BIO
Iome Bio is a biotechnology company based in France, founded in 2020. The company is focused on harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncology. With a slogan of "Harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncology," Iome Bio aims to...
Microbiome Insights, Immuno-oncology, PD/L-1 Therapies, Cancer Treatment, R&D Programs, Live Biotherapeutics, Monoclonal Antibodies, French Biotech Company, Immuno-oncology Drugs, Checkpoint Inhibitors, Tumor Microenvironment, Drug Resistance, Harvard Laboratories, First In Class, Clinical Data
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around IOME BIO: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at IOME BIO on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
